550 related articles for article (PubMed ID: 34811869)
1. IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.
Kaddu-Mulindwa D; Keuser L; Lesan V; Rissland J; Smola S; Werdecker V; Stilgenbauer S; Christofyllakis K; Thurner L; Bewarder M; Lohr B; Lutz J; Lohse S; Rieke A
HIV Med; 2022 May; 23(5):564-569. PubMed ID: 34811869
[TBL] [Abstract][Full Text] [Related]
2. HIV and SARS-CoV-2 co-infection: cross-sectional findings from a German 'hotspot'.
Noe S; Schabaz F; Heldwein S; Mayer W; Ruecker K; Tiller FW; von Krosigk A; Wiese C; Balogh A; Gersbacher E; Jonsson-Oldenbuettel C; Jaeger H; Wolf E;
Infection; 2021 Apr; 49(2):313-320. PubMed ID: 33387261
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study.
Spinelli MA; Lynch KL; Yun C; Glidden DV; Peluso MJ; Henrich TJ; Gandhi M; Brown LB
Lancet HIV; 2021 Jun; 8(6):e334-e341. PubMed ID: 33933189
[TBL] [Abstract][Full Text] [Related]
4. The seroprevalence of COVID-19 in patients living with HIV in metropolitan Detroit.
Gudipati S; Lee M; Scott M; Yaphe S; Huisting J; Yared N; Brar I; Markowitz N
Int J STD AIDS; 2022 May; 33(6):554-558. PubMed ID: 35333100
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 seroprevalence among people living with HIV in Guinea-Bissau.
Dutschke A; Wejse C; Nanque JP; Medina C; Hønge BL; Jespersen S;
Public Health; 2022 Aug; 209():36-38. PubMed ID: 35785597
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence and indexes of IgG antibodies for SARS-CoV-2 infection among People Living With HIV, tuberculosis patients and healthcare workers, in Salvador, Brazil.
de Santana DS; Netto EM; Vaz SN; Dantas PH; Brites C
Braz J Infect Dis; 2023; 27(5):102811. PubMed ID: 37813359
[TBL] [Abstract][Full Text] [Related]
7. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 seroprevalence and associated factors, based on HIV serostatus, in young people in Sofala province, Mozambique.
Benoni R; Casigliani V; Zin A; Giannini D; Ronzoni N; Di Chiara C; Chhaganlal K; Donà D; Merolle A; Dos Anjos HG; Chenene F; Tognon F; Putoto G; Giaquinto C
BMC Infect Dis; 2023 Nov; 23(1):809. PubMed ID: 37978353
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study.
D'Souza G; Tong W; Gustafson D; Alcaide ML; Lahiri CD; Sharma A; French AL; Palella FJ; Kempf MC; Mimiaga MJ; Ramirez C; Kassaye S; Rinaldo CR; Brown TT; Tien PC; Adimora AA
J Acquir Immune Defic Syndr; 2022 Jan; 89(1):1-8. PubMed ID: 34878431
[TBL] [Abstract][Full Text] [Related]
10. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
[TBL] [Abstract][Full Text] [Related]
11. Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China.
Huang X; Yan Y; Su B; Xiao D; Yu M; Jin X; Duan J; Zhang X; Zheng S; Fang Y; Zhang T; Tang W; Wang L; Wang Z; Xu J
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215870
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study.
Leone V; Meisinger C; Temizel S; Kling E; Gerstlauer M; Frühwald MC; Burkhardt K
PLoS One; 2022; 17(8):e0272874. PubMed ID: 35951611
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Infection Is Associated with Uncontrolled HIV Viral Load in Non-Hospitalized HIV-Infected Patients from Gugulethu, South Africa.
Lambarey H; Blumenthal MJ; Chetram A; Joyimbana W; Jennings L; Tincho MB; Burgers WA; Orrell C; Schäfer G
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746693
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological, Virological and Serological Features of Coronavirus Disease 2019 (COVID-19) Cases in People Living With Human Immunodeficiency Virus in Wuhan: A Population-based Cohort Study.
Huang J; Xie N; Hu X; Yan H; Ding J; Liu P; Ma H; Ruan L; Li G; He N; Wei S; Wang X
Clin Infect Dis; 2021 Oct; 73(7):e2086-e2094. PubMed ID: 32803216
[TBL] [Abstract][Full Text] [Related]
18. IgG Seroprevalence of COVID-19 among Individuals without a History of the Coronavirus Disease Infection in Daegu, Korea.
Song SK; Lee DH; Nam JH; Kim KT; Do JS; Kang DW; Kim SG; Cho MR
J Korean Med Sci; 2020 Jul; 35(29):e269. PubMed ID: 32715672
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of Novel Coronavirus SARS-CoV-2 at a Community Hospital Emergency Department and Outpatient Laboratory in Northern Orange County, California.
Yamaki J; Peled H; Mathews S; Park D; Firoozi M; Smith K; Nguyen L
J Racial Ethn Health Disparities; 2021 Dec; 8(6):1551-1555. PubMed ID: 33230735
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among HIV Infected Individuals Attending ART Centre at Pune: A Cross-Sectional Study.
Ghate M; Shidhaye P; Gurav S; Gadhe K; Kale V; Jain P; Thakar M
J Int Assoc Provid AIDS Care; 2022; 21():23259582221077943. PubMed ID: 35128977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
